0001213900-21-021025.txt : 20210409
0001213900-21-021025.hdr.sgml : 20210409
20210409161537
ACCESSION NUMBER: 0001213900-21-021025
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210407
FILED AS OF DATE: 20210409
DATE AS OF CHANGE: 20210409
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Rothbard Jonathan B.
CENTRAL INDEX KEY: 0001833968
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38105
FILM NUMBER: 21818018
MAIL ADDRESS:
STREET 1: 501 BEALE STREET
STREET 2: UNIT 8D
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94105
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: 180 Life Sciences Corp.
CENTRAL INDEX KEY: 0001690080
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 813832378
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 830 MENLO AVENUE, SUITE 100
CITY: MENLO PARK
STATE: CA
ZIP: 94025
BUSINESS PHONE: 650-507-0669
MAIL ADDRESS:
STREET 1: 830 MENLO AVENUE, SUITE 100
CITY: MENLO PARK
STATE: CA
ZIP: 94025
FORMER COMPANY:
FORMER CONFORMED NAME: KBL MERGER CORP. IV
DATE OF NAME CHANGE: 20161115
4
1
ownership.xml
OWNERSHIP DOCUMENT
X0306
4
2021-04-07
0
0001690080
180 Life Sciences Corp.
ATNF
0001833968
Rothbard Jonathan B.
830 MENLO AVENUE, SUITE 100
MENLO PARK
CA
94025
0
1
0
0
Chief Scientific Officer
Common Stock
2021-04-07
4
A
0
24307
6.14
A
560449
D
Issued in consideration for accrued compensation due for services rendered as Chief Scientific Officer of the Issuer. Granted under the registrant's 2020 Omnibus Incentive Plan. Exempt from Section 16(b) pursuant to Rule 16b-3.
/s/ Jonathan B. Rothbard, Ph.D.
2021-04-09